Markets:

Overview

News

Currencies

International

Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

166.82 +2.33 (+1.41%)

Streaming Delayed Price Updated: 11:57 AM EST, Feb 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

3 Biotech Stocks That Could Be Millionaire Makers ↗

November 22, 2023

Many biotech stocks offer exciting long-term growth prospects.

Via The Motley Fool

Police Boss Turned Cannabis Reform Advocate, MMJ Legalization In Japan And More Global Updates ↗

November 16, 2023

Medical Cannabis-Based Epidiolex Advances Through Japan's Legislature Earlier this week, Japanese policymakers gave the green light to a measure to legalize medical products derived from cannabis,...

Via Benzinga

Topics Cannabis

3 No-Brainer Stocks to Buy With $200 Right Now ↗

November 15, 2023

A modest amount of money can go a long way when it's invested in inexpensive, game-changing businesses.

Via The Motley Fool

Autifony Announces Exclusive Global License and Collaboration Agreement with Jazz Pharmaceuticals on Two Ion Channel Targets for Neurological Disorders

November 14, 2023

From Autifony Therapeutics Ltd

Via Business Wire

Jazz Pharmaceuticals: Q3 Earnings Insights ↗

November 08, 2023

Via Benzinga

Where Jazz Pharmaceuticals Stands With Analysts ↗

September 29, 2023

Via Benzinga

7 Healthcare Stocks That Are Poised to Become the Next Unicorns ↗

November 09, 2023

Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.

Via InvestorPlace

Cannabis Cash Burn Concerns? Sell These 7 Overbought Stocks Now. ↗

November 07, 2023

These overbought cannabis stocks are teetring on the edge as the sector is navigating through uncharted waters.

Via InvestorPlace

Topics Cannabis

FDA Report On Its 50 Years In Cannabis Research, Signals A Boost In Medical Marijuana Prospects ↗

November 03, 2023

Researchers with the Food and Drug Administration (FDA) reported Wednesday on the agency’s 50 years of experience with marijuana research. In an article titled “FDA’s 50

Via Benzinga

Topics Cannabis

Ireland Reimburses Medical Marijuana-Based Drug For Chemotherapy-Induced Nausea And Vomiting ↗

October 30, 2023

Althea Group Holdings Limited (ASX: AGH), an Australian manufacturer of cannabis-based medicines and recreational cannabis products confirmed that Ireland’s Primary Care Reimbursement...

Via Benzinga

Topics Cannabis

Global Cancer Vaccines Market Share Is Expected To Reach $19.27 Billion By 2030

October 25, 2023

EQNX::TICKER_START (OTCPK:DTCFF),(CSE:DTC),(NASDAQ:JAZZ),(NASDAQ:EXEL),(NASDAQ:AMGN),(NASDAQ:REGN) EQNX::TICKER_END

Via FinancialNewsMedia

Europe's High: UK Parents Need NHS Help For Daughter's Seizures, THC MMJ Flowers In Switzerland & More ↗

October 24, 2023

Luxembourg: Medical Marijuana Shortage Due To Supplier Change

Via Benzinga

Topics Cannabis Supply Chain

Cannabis Stocks Dip: How Rising Interest Rates Impact Your Portfolio ↗

October 23, 2023

On Friday, cannabis stocks traded lower with the overall market. Marketfy analyst Michael Berger will be monitoring how the sector performs this week.

Via Benzinga

Topics Cannabis

Europe's High: Irish GPs Against Pot, Switzerland-Spain Share Data On Cannabis Clubs & More ↗

October 20, 2023

Denmark: Medical Marijuana Pilot Program Experience 90% Growth In 12 Months

Via Benzinga

Topics Cannabis

Jazz Pharmaceuticals Explores Asset Sale Option, Possibly Cannabinoid Business: Report ↗

October 20, 2023

Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) is reportedly exploring strategic options comprising a potential sale.

Via Benzinga

2 Top Biotech Stocks to Buy in October ↗

October 03, 2023

Growth catalysts lie ahead for both of these players.

Via The Motley Fool

5 Genius Safe Stocks to Buy for the 4th Quarter of 2023 ↗

October 02, 2023

These highly profitable, time-tested companies can deliver for their shareholders in any economic climate.

Via The Motley Fool

4 Perfect Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip ↗

September 30, 2023

An 18% decline in the Nasdaq Composite from its all-time high means bargains still abound.

Via The Motley Fool

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023 ↗

September 29, 2023

Via Benzinga

3 Cannabis Stocks That Should Be on Every Investor’s Radar This Fall ↗

September 27, 2023

The cannabis industry is a quiet place where huge upside potential is building up. As more regions legalize, cannabis stocks can soar.

Via InvestorPlace

Topics Cannabis

Revolutionary Cancer Treatment Advances Promise Brighter Future Amid Federal Funding Uncertainty

September 22, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 22, 2023 – USA News Group – Despite the potential federal funding challenges due to the recent debt ceiling deal,...

Via FinancialNewsMedia

3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall ↗

September 20, 2023

Even with higher for longer interest rates, drug discovery moves on. That’s why it’s still a good time to look for biotech stocks to buy.

Via InvestorPlace

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

September 20, 2023

Via Investor Brand Network

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

September 20, 2023

EQNX::TICKER_START (NASDAQ:GNPX),(OTCQX:RHHBY),(NASDAQ:JAZZ),(NASDAQ:ALXO),(NASDAQ:ACHL) EQNX::TICKER_END

Via FinancialNewsMedia

7 Cannabis Stocks to Buy BEFORE the Marijuana Rescheduling Boom ↗

September 19, 2023

Cannabis stocks re seeing renewed interest and these seven look like reasonable buys as rescheduling approaches for weed.

Via InvestorPlace

Topics Cannabis

Cannabis Industry Changes As Marijuana Rescheduling Looms ↗

September 15, 2023

As the Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, investors and leaders in the cannabis industry, let's scroll through the top...

Via Benzinga

Topics Cannabis

NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years ↗

September 12, 2023

NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections until 2035.

Via Benzinga

Prediction: These Could Be the Best-Performing Cannabis Stocks Through 2030 ↗

August 26, 2023

These two businesses may be sound, but generating returns in this industry has been tough, with no light at the end of the tunnel.

Via The Motley Fool

Topics Cannabis

Epidiolex Counterpart Debuts In Brazil's Cannabis Market As Its Maker Eyes TSX IPO ↗

August 23, 2023

Verdemed, a pharmaceutical company known for producing cannabis-derived products, has received five fresh approvals from the Brazilian Health Regulatory Agency (Agência Nacional de Vigilância...

Via Benzinga

Topics Cannabis

Jazz Pharmaceuticals' Neuroscience Pipeline Readouts In Focus: Analyst Lowers Price Target ↗

August 14, 2023

Cantor Fitzgerald analyst Charles C.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

CONCORD NEWS IN YOUR INBOX: SIGN UP HERE

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

All News about Jazz Pharmaceuticals plc - Ordinary Shares

The Newspapers of New England Family

We continue to need local support from our readers

Enjoying the Concord Monitor?

CONCORD NEWS IN YOUR INBOX: SIGN UP HERE

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

All News about Jazz Pharmaceuticals plc - Ordinary Shares

Sign in